Discovery of 3-Methyl-N-(1-Oxy-3, 4, 5, 6-Tetrahydro-2h-[2, 4-Bipyridine]-1-Ylmethyl)benzamide (ABT-670), an Orally Bioavailable Dopamine D4 Agonist for the Treatment of Erectile Dysfunction

doi 10.1021/jm060662k.s001